E-LIB Suche - Ergebnisse für: Hwang, Thomas J

1

EDITORIAL COMMENT:

Hwang, Thomas ; Weiss, Robert E.
Urology. 174 (2023) - p. 116-117 , 2023

Link: https://doi.org/10.1016/..

2

Signal Attenuation-Compensated Projection-Resolved OCT Angi..:

Wang, Jie ; Hormel, Tristan ; Bailey, Steven...
Biomedical Optics Express. , 2023

Link: https://doi.org/10.1364/..

3

Concurrent Xanthogranulomatous Pyelonephritis and Upper Uri..:

Guglin, Anthony ; Weiss, Robert ; Singh, Adityabikram...
Case Reports in Urology. 2023 (2023) - p. 1-4 , 2023

Link: https://doi.org/10.1155/..

4

Single-shot OCT and OCT angiography for slab-specific detec..:

LIANG, GUANGRU ; Hormel, Tristan ; Wei, Xiang...
Biomedical Optics Express. , 2023

Link: https://doi.org/10.1364/..

5

Therapeutic value of first versus supplemental indications ..:

Vokinger, Kerstin N ; Glaus, Camille E G ; Kesselheim, Aaron S...
BMJ. , 2023

Link: https://doi.org/10.1136/..

6

Lifecycle Regulation and Evaluation of Artificial Intellige..:

, In: The Future of Medical Device Regulation,

Vokinger, Kerstin N. ; Hwang, Thomas J. ; Kesselheim, Aaron S. - p. 13-21 , 2022

Link: https://doi.org/10.1017/..

7

Medicaid Expenditures and Estimated Rebates on Line Extensi..:

Hwang, Thomas J. ; Feng, Josh ; Maini, Luca.
Journal of General Internal Medicine. 37 (2022) 14 - p. 3769-3771 , 2022

Link: https://doi.org/10.1007/..

8

Reforms to accelerated approval of new medicines: long over..:

Hwang, Thomas J ; Trinh, Quoc-Dien ; Tibau, Ariadna.
The Lancet. 400 (2022) 10349 - p. 357-358 , 2022

Link: https://doi.org/10.1016/..

9

Coverage of New Drugs in Medicare Part D:

NACI, HUSEYIN ; KYRIOPOULOS, ILIAS ; FELDMAN, WILLIAM B....
The Milbank Quarterly. 100 (2022) 2 - p. 562-588 , 2022

Link: https://doi.org/10.1111/..

10

Prices and clinical benefit of cancer drugs in the USA and ..:

Vokinger, Kerstin N ; Hwang, Thomas J ; Grischott, Thomas...
The Lancet Oncology. 21 (2020) 5 - p. 664-670 , 2020

Link: https://doi.org/10.1016/..

11

Association between FDA and EMA expedited approval programs..:

Hwang, Thomas J ; Ross, Joseph S ; Vokinger, Kerstin N.
BMJ. , 2020

Link: https://doi.org/10.1136/..

12

Association between FDA and EMA expedited approval programs..:

Hwang, Thomas J ; Ross, Joseph S ; Vokinger, Kerstin N.
BMJ: British Medical Journal. 371 (2020) - p. 1-8 , 2020

Link: https://www.jstor.org/st..

13

Clinical benefit and cost of breakthrough cancer drugs appr..:

Molto, Consolación ; Hwang, Thomas J. ; Borrell, Maria...
Cancer. 126 (2020) 19 - p. 4390-4399 , 2020

Link: https://doi.org/10.1002/..

14

Pediatric Trials for Cancer Therapies With Targets Potentia..:

Bourgeois, Florence T ; Janeway, Katherine A ; DuBois, Steven G..
JNCI: Journal of the National Cancer Institute. 112 (2019) 3 - p. 224-228 , 2019

Link: https://doi.org/10.1093/..

15

European Medicines Agency's Priority Medicines Scheme at 2 ..:

Neez, Emilie ; Hwang, Thomas J. ; Sahoo, Samali Anova.
Clinical Pharmacology & Therapeutics. 107 (2019) 3 - p. 541-552 , 2019

Link: https://doi.org/10.1002/..